A strong EU pharmaceutical sector is essential to ensure Europe’s disease prevention capabilities, preparedness and assure our health 'independence'. If we want to foster medical research, facilitate patient access and boost the competitiveness of Europe’s life sciences industry, a sectoral political approach is needed. This can be facilitated by the launch of a new EU strategic dialogue between key stakeholders.
Towards an integrated EU policy approach for the pharmaceutical sector
Photo gallery
-
EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'
Cristian-Silviu Buşoi MEP (EPP Group, Romania), Member of the Civil Liberties, Justice and Home Affairs Committee of the European Parliament
30.09.2015European Parliament in BrusselsDownload Original (488 KB)
-
EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'
View of the meeting room
30.09.2015European Parliament in BrusselsDownload Original (745.96 KB)
-
EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'
Françoise Grossetête MEP (France), Vice-Chairwoman of the EPP Group in the European Parliament
30.09.2015European Parliament in BrusselsDownload Original (337.57 KB)
-
EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'
Françoise Grossetête MEP (France), Vice-Chairwoman of the EPP Group in the European Parliament, Ruxandra Draghia-Akli, Director, Health Directorate, DG Research, European Commission, and Stefan Oelrich, General Manager Germany, Switzerland, Austria, Sanofi
30.09.2015European Parliament in BrusselsDownload Original (579.97 KB)
-
EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'
Mary Harney, Former Minister for Enterprise, Trade and Employment and Former Minister for Health and Children, Ireland
30.09.2015European Parliament in BrusselsDownload Original (520.1 KB)
-
EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'
Pierre Meulien, Executive Director, Innovative Medicines Initiative
30.09.2015European Parliament in BrusselsDownload Original (437.97 KB)
-
EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'
Dr Jordi Llinares Garcia, Head of Human Medicines Research and Development Support Division, European Medicines Agency
30.09.2015European Parliament in BrusselsDownload Original (471.44 KB)
-
EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'
Nathalie Moll, Secretary General, EuropaBio
30.09.2015European Parliament in BrusselsDownload Original (464.13 KB)
Latest
EU future, terror financing, journalist murders, Facebook scandal
Tough rules against terror money and tax evasion
What has the Slovak Government done to protect journalists
European Parliament stops Dieselgate from happening again
Highlights of the week

Towards new rules on the posting of workers

Action needed to combat mileage fraud in Europe

Dual quality products in the Single Market
Press Contacts

